Hepion Pharmaceuticals, Inc. (HEPA) Risk Assessment & Volatility Analysis

Comprehensive risk assessment and volatility analysis for HEPA including beta analysis, market risk, financial risk, and investment risk evaluation. Understand the potential risks and rewards of investing in HEPA stock with expert risk management insights.

Risk Assessment Summary

High price volatility

High debt levels

Governance Risk

Overall Risk Score

N/A

Audit Risk

N/A

Board Risk

N/A

Compensation Risk

N/A

Shareholder Rights Risk

N/A

Market Risk

Beta (5Y Monthly)

N/A

52-Week Change

-99.79%Low

S&P 500 52-Week Change

13.26%Very High

Short Interest Ratio

0.05Low

Short % of Float

4.10%Very High

Volatility (Annualized)

223.91%Very High

Financial Risk

Total Debt

$214.31K

Enterprise Value

$343.68K

Profit Margins

0.00%Very High

Earnings Growth (QoQ)

N/A

Net Income to Common

$-9168419.00

Book Value

$0.14

Risk vs Reward Analysis

Risk Factors

Beta: N/A

Volatility: 223.91%

Short Interest: 0.05

Potential Rewards

52-Week Change: -99.79%

Earnings Growth: N/A

Profit Margin: 0.00%